Radiation Oncology

Print Page Print   EmailEmail   Bookmark Page Bookmark   RSS Feeds RSS

 

Elizabeth M. Gore, MD

                             

Elizabeth M. Gore, MD
Associate Professor of Radiation Oncology
Associate Director, Radiation Oncology at Zablocki VA Medical Center

Department of Radiation Oncology
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 805-4465

  ___________________________________
   Additional Information (curriculum vitae)
 ___________________________________

Patient Care Emphases

  • General Radiation Oncology
  • Lung Cancer
  • Esophageal Cancer

Clinical Practice Locations

  • Zablocki VA Medical Center: (414) 384-2000, ext. 42585
  • Radiation Oncology Clinic at Froedtert & Medical College Clinics: (414) 805-4400

Education

  • Doctor of Medicine,  Medical College of Wisconsin,  Milwaukee, WI (1990).

Training

  • Recertified American Board of Radiology (2000).
  • Board Certified American Board of Radiology (1995).
  • Fellowship Radiation Oncology, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI (1994-1995).
  • Residency Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI (1990-1994).

Representative Publications

  • GORE E, Gillin MT, Albano K, Erickson B.  Comparison of High Dose Rate (HDR) and Low Dose Rate Distributions for Vaginal Cylinders.  International Journal of Radiation Oncology, Biology, Physics 31(1):165-170, 1995.
  • GORE EM, Lawton CA, Ash RC, Lipchik RJ:  Pulmonary Function changes in Long-term Survivors of Bone Marrow Transplantation. International Journal of Radiation Oncology, Biology, Physics 36:67-75, 1996.
  • Jones R, GORE E, Meiler W, Murray K, Gillin M, Albano K, Erickson B.  Post-treatment Visual Acuity in Patients Treated with Episcleral Plaque Therapy for Choroidal Melanoma: Dose and Dose Rate Effects. International Journal of Radiation Oncology, Biology, Physics 52(4):989-995, 2002.
  • Firat S, Bousamra M, GORE E, Byhardt R.  Comorbidity and KPS are independent prognostic factors in Stage I non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 52(4):1047-1057, 2002.
  • Firat S, Byhardt R, GORE E.  Comorbidity and KPS are independent prognostic factors in Stage III non-small cell lung cancer (NSCLC): An institutional analysis of NSCLC patients treated on 4 RTOG studies.  International Journal of Radiation Oncology, Biology, Physics, 54(2):357-64, 2002.
  • Firat S, GORE E, Byhardt R.  Do "elderly fit" patients have less comorbidity?  International Journal of Radiation Oncology, Biology, Physics, 55(5):1166-1168, 2003.
  • GORE, EM.  Prophylactic cranial irradiation for patients with locally advanced non-small cell lung cancer.  Oncology (Huntington) 17(6):775-9, 2003.
  • GORE E.  Prophylactic Cranial Irradiation for Non-Small Cell Lung Cancer.  Seminars in Radiation Oncology Accepted for publication October 2003, to be published October 2004
  • GORE E.  Radiation Therapy of Lung Cancer in Elderly Patients. Journal of Clinical Oncology, American Society of Clinical Oncology 2005 Educational Book from 41st Annual Meeting, May 2005.

  • Firat S, Pleister A, Byhardt R, GORE E.  Age is Independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC) American Journal of Clinical Oncology 29(3), June 2006


Abstracts

  • Bradley JD, Graham M, Suzanne S, Byhardt R, Govindan R, Fowler J, Purdy J, Michalski J, GORE E, Choy H.  Phase I results of RTOG L0117; A phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC.  Presented at 2005 ASCO Annual Meeting  May 2005, Orlando, FL.
  • Ng AV, Alt C, GORE E, et al.  Mechanisms of fatigue in cancer survivors.  Medicine & Science in Sports & Exercise: Abstract Issue 2006,38 Suppl. Abstract in Press. 

 

webmaster@mcw.edu
© 2007 Medical College of Wisconsin
Page Updated 12/11/2007